A review of clinical studies in elderly populations
FILL IN YOUR DETAILS TO ACCESS TO THE WEBINAR
About the webinar
What can you expect of our webinars?
ON DEMAND WEBINAR | AVAILABLE NOW
Duration: 25 min
Abstract: In 2018, people aged 65 years or over worldwide, outnumbered children under age five for the first time in history. By 2050, an estimated of 1.5 billion people will be aged 65 or older. The healthy ageing industry is expected to become highly competitive and profitable.
In functional food industries, differentiation is key. The first step of which is to prove the health benefits potentially associated with products. Human clinical studies are considered the gold standard method for the scientific substantiation of claims by the main health institutions and a powerful marketing and sales tool. However, there are some challenges and considerations when designing and conducting clinical trials involving elderly participants.
Join us to unveil the secrets of human clinical studies within an ageing population.
Barry Skillington | Chief Commercial Officer at Atlantia
Barry Skillington has over 25 years’ experience working in the commercial food sector in both product development and business development, in both Ireland and in the USA. Having spent the last seven years at Atlantia as CCO, he has helped build the brand and customer base to where it is today as one of Europe’s leading Food Clinical Trials companies.
Emily Goodbody | Senior Project Manager at Atlantia
Emily Goodbody has an MSc in Clinical Nutrition and has worked with Atlantia for over 6 years. She has worked on a multitude of clinical trials in different health areas and is involved in the management and day to day running of the clinical trial.